Public Health Issues

  1. COVID-19
  2. Mpox


CDC Information for Health Care Professionals:

Monoclonal Antibody Treatments for COVID-19 (Bamlanivimab and Regeneron): The linked letter and referral form below are intended to provide updated information regarding the referral process and available Maryland infusion sites for the two FDA EUA-approved monoclonal antibody (mAb) treatments for COVID-19: bamlanivimab (Eli Lilly) and the antibody combination, casirivimab/imdevimab (Regeneron).   Early data for these therapeutics suggest that they may reduce the risk of hospitalization for people at high risk who have tested positive for COVID-19 and have only mild to moderate symptoms.

Starting April 2022, calls will be held monthly on the first Thursday at noon. Some summary slides are available on off weeks.